A 36-yr-old female patient is receiving treatment for chronic hepatitis C with pegylated interferon (PEG-Intron,Pegasys),ribavirin (Rebetol),and telaprevir (Incivek). Which finding is important to communicate to the health care provider to suggest a change in therapy?

Question

Quizplus · Accepted Answer

Because ribavirin is teratogenic,the medication will need to be discontinued immediately. Anemia,weight loss,and nausea are common adverse effects of the prescribed regimen and may require actions such as patient teaching,but they would not require immediate cessation of the therapy.

A 36-Yr-Old Female Patient Is Receiving Treatment for Chronic Hepatitis